ChromaCode Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 113
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $45M
Latest Deal Amount
  • Investors
  • 9

ChromaCode General Information

Description

Developer of molecular diagnostics technology designed to focus on bioinformatics and pedigree. The company's technology leverages patented mathematical methods and algorithmic enhancements to enrich signal processing from the life science instrumentation by producing signal patterns for each combination of targets, enabling the healthcare industry and laboratory customers to improve the capabilities of biochemical assays at lower costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Business/Productivity Software
Discovery Tools (Healthcare)
Primary Office
  • 2330 Faraday Avenue
  • Suite 100
  • Carlsbad, CA 92008
  • United States
+1 (442) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ChromaCode Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 03-Dec-2020 $45M 000.00 0000 Completed Generating Revenue
2. Early Stage VC (Series B) 25-Apr-2017 0000 000.00 0000 Completed Generating Revenue
1. Early Stage VC (Series A1) 13-Aug-2015 $2.2M $2.2M 00.00 Completed Generating Revenue
To view ChromaCode’s complete valuation and funding history, request access »

ChromaCode Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A1 10,805,082 $0.000100 $0.02 $0.24 $0.24 1x $0.24 8.62%
To view ChromaCode’s complete cap table history, request access »

ChromaCode Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of molecular diagnostics technology designed to focus on bioinformatics and pedigree. The company's technology
Other Healthcare Technology Systems
Carlsbad, CA
113 As of 2021
000.00
000 0000-00-00
00000000000 000.00

000000 0

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia
0000000000 00000000 (0000000000)
Los Angeles, CA
0000000000

00000 00

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
0000000000 000000000
Malvern, PA
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ChromaCode Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nesher Technologies Corporation Los Angeles, CA 0000000000
00000 0000000 Venture Capital-Backed Malvern, PA 00 000.00 00000000000 000.00
000 000000000 0000 Formerly VC-backed Tucson, AZ 00 00000 000000000 - 00000
00000000 Venture Capital-Backed Redwood City, CA 000 00000 00000000000 00000
0-00000 Formerly VC-backed Uppsala, Sweden 000 00000 00000000 00000
You’re viewing 5 of 10 competitors. Get the full list »

ChromaCode Patents

ChromaCode Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200399677-A1 Methods for differentially quantifying nucleic acids Pending 24-Jun-2019 000000000
EP-3847181-A1 Universal tail primers with multiple binding motifs for multiplexed detection of single nucleotide polymorphisms Pending 07-Sep-2018 0000000000
US-20210189473-A1 Universal tail primers with multiple binding motifs for multiplexed detection of single nucleotide polymorphisms Pending 07-Sep-2018 0000000000
US-20210292817-A1 Methods for quantitation of analytes in multiplexed biochemical reactions Pending 11-Jul-2018 0000000000
EP-3821034-A1 Methods for quantitation of analytes in multiplexed biochemical reactions Pending 11-Jul-2018 C12Q1/6816
To view ChromaCode’s complete patent history, request access »

ChromaCode Executive Team (9)

Name Title Board Seat Contact Info
Gregory Gosch Co-Founder, Chief Executive Officer, President and Board Member
Aditya Rajagopal Ph.D Co-Founder, Chief Technology Officer & Board Member
Brett Brown Vice President, Finance and Administration
Karen Menge Ph.D Vice President of Research & Development
Alexander Dickinson Ph.D Co-Founder, Executive Chairman and Board Member
You’re viewing 5 of 9 executive team members. Get the full list »

ChromaCode Board Members (9)

Name Representing Role Since
Aditya Rajagopal Ph.D ChromaCode Co-Founder, Chief Technology Officer & Board Member 000 0000
Alexander Dickinson Ph.D ChromaCode Co-Founder, Executive Chairman and Board Member 000 0000
Carol Gallagher MD New Enterprise Associates Board Member 000 0000
James Blair Ph.D Domain Associates Board Member 000 0000
Jenny Yip Adjuvant Capital Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

ChromaCode Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ChromaCode Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adjuvant Capital Impact Investing Minority 000 0000 000000 0
California Institute of Technology Endowment Limited Partner Minority 000 0000 000000 0
In-Q-Tel Not-For-Profit Venture Capital Minority 000 0000 000000 0
Moore Venture Partners Venture Capital Minority 000 0000 000000 0
Northpond Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »